Author | Charles H. Kellner, MD

Articles

The FDA on ECT: Supporting a Vital Treatment

June 25, 2019

Article

This new FDA order now allows patients who need and want ECT, as well as practitioners who perform it, to breathe a sigh of relief.

The Role of ECT in the Suicide Epidemic

August 24, 2018

Article

The recent increase in suicides highlights the urgent need for better treatment of severe depression. ECT is an intervention proven to reduce suicidality, yet it is underused because of the associated stigma.

ECT for Self-Injurious Behavior in Autism: A New Indication

February 15, 2018

Article

ECT has been found effective in mitigating the deleterious consequences of SIB.

ECT for Catatonia and Melancholia: No Need for Ambivalence

September 28, 2017

Article

For ethical and economic reasons, when patients are acutely ill with catatonia and melancholia, ECT is best considered sooner rather than later.

Contemporary ECT, Part 2: Mechanism of Action and Future Research Directions

August 26, 2015

Article

Simply telling patients “we don’t know how ECT works” neglects our abundant knowledge of what this treatment does. The authors review biological actions of ECT and discuss future directions for research.

Contemporary ECT for Depression Part 1: Practice Update

July 30, 2015

Article

This review covers recent advances in ECT technique, post-ECT management, and theories of mechanism of action. It will focus on the use of ECT in depression, the most common indication for ECT in clinical practice.

Brain Stimulation With ECT: Neuroscience Insights From an Old Treatment

January 22, 2015

Article

Some recent breakthroughs, using newly developed neuroscience investigational tools, suggest that if research resources are available, we could soon make substantial advances in understanding the mechanism of action of ECT.

Ketamine Anesthesia for Electroconvulsive Therapy

May 09, 2014

Article

The authors review the clinical use of ketamine as the anesthetic induction agent in ECT and discuss the evidence that it augments antidepressant response and reduces cognitive adverse effects.

ECT and Catatonia: Out of the Shadows

December 26, 2013

Article

Catatonia-a syndrome of disturbed motor, mood, and systemic signs (eg, rigidity, immobility, mutism, staring, posturing, waxy flexibility, echopraxia, echolalia, and stereotypies)-has led to the clarification of its appropriate treatment.

ECT for Treatment-Resistant Depression: The State of the Art

February 04, 2013

Article

For patients with treatment-resistant depression-especially geriatric patients-ECT is a viable treatment option . . . one that should no longer be relegated to the option of last resort.

x